Solution
Industries
Resources
About
  1. Press Releases
  2. 2009
  3. Cell Biology

Proteomics: Technologies and Global Markets

July 08, 2009

 

Wellesley, Mass. — According to a new technical market research report, PROTEOMICS: TECHNOLOGIES AND GLOBAL MARKETS (BIO034B) from BCC Research (www.bccresearch.com), the global market for proteomics was worth $6.7 billion in 2008 and an estimated $7.9 billion in 2009. This is expected to reach $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%.
 
The market is broken down into segments for equipment, technology, services, and database and software. Of these, proteomics equipment is currently the largest segment of the market, generating $4.1 billion in 2008. This is expected to increase to $4.8 billion in 2009 and more than $13 billion in 2014, for a CAGR of 21.9%.
 
The second-largest share of the market currently belongs to proteomics technology, which generated $1.3 billion in 2008. This segment is expected to generate $1.5 billion in 2009 and $2.9 billion in 2014, for a CAGR of 13.9%.
 
Proteomics services make up the third-largest market segment, worth $748.1 million in 2008 and an estimated $885.2 million in 2009. This should increase to $2.1 billion in 2014, for a CAGR of 18.8%.
 
SUMMARY FIGURE
GLOBAL PROTEOMICS MARKET BY EQUIPMENT, DATABASE AND SOFTWARE, TECHNOLOGY, AND SERVICES, 2007-2014
($ MILLIONS)
GLOBAL PROTEOMICS MARKET BY EQUIPMENT, DATABASE AND SOFTWARE, TECHNOLOGY, AND SERVICES, 2007-2014
To Contact us, click here  help


Source: BCC Research
 
Proteomics is the study of the structure and function of proteins in a gene. It has various uses starting from identifying proteins and performing a protein-expression profile by identifying the protein in a specific state of an organism.
 
The market encompasses significant driving forces that indicate high-growth prospects. The key buyers of proteomics include diagnostics companies, drug development companies, and healthcare institutes. Other buyers include food and nutrition centers and physical surveillance centers (homeland security). The key buyers account for more than 70% of the market.

Proteomics, which enables effective analysis of the function and structure of biological systems, is evolving into an important tool in the field of life sciences. It is being used in the field of diagnosis for therapy and treatment of diseases such as cancer and Alzheimer’s disease, among others. Technological advancements and increasing applications of proteomics for drug discovery are helping drug manufacturers to develop more efficient and effective drugs, and reduce substantial development costs.

Proteomics: Technologies and Global Markets( BIO034B )
Publish Date: Jun 2009    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.

BCC Library Membership Benefits

Unlimited Access to Market Research Reports for Academic Institutions and Corporations.

Custom Research

Tailored solutions across industries for your unique business needs.

Proteomics: Technologies and Global Markets
Customize This Report

More in Cell Biology

Reports from Cell Biology

Recent News

Browse by Year

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2026 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment